Jean-Philippe Lanoix

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 14

Top Topics

High Fat Diet Induced

Helicobacter Pylori

Top Venues

Antimicrobial agents and chemotherapy

AIDS and behavior

JAC-antimicrobial resistance

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eloïse Delpierre, Jean-Philippe Lanoix
Successful prophylaxis of ESBL Enterobacteriaceae repetitive urinary tract infections with subcutaneous temocillin: a case report. JAC-antimicrobial resistance 6 (1) (2024)
Eloïse Delpierre, Jean-Philippe Lanoix
Successful prophylaxis of ESBL Enterobacteriaceae repetitive urinary tract infections with subcutaneous temocillin: a case report. JAC-antimicrobial resistance 6 (1) (2024)
Loren L Toussaint, Sebastian Binyamin Skalski, Jean-Philippe Lanoix, Karol Konaszewski, Janusz Surzykiewicz
The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in France. AIDS and behavior (2023)
Loren L Toussaint, Sebastian Binyamin Skalski, Jean-Philippe Lanoix, Karol Konaszewski, Janusz Surzykiewicz
The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in France. AIDS and behavior (2023)
Loren L Toussaint, Sebastian Binyamin Skalski, Jean-Philippe Lanoix, Karol Konaszewski, Janusz Surzykiewicz
The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in France. AIDS and behavior (2023)
Loren L Toussaint, Sebastian Binyamin Skalski, Jean-Philippe Lanoix, Karol Konaszewski, Janusz Surzykiewicz
Correction to: The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in France. AIDS and behavior (2023)
Florence Dupont, Aurélien Aubry, Jean-Philippe Lanoix, Baptiste Demey
Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent Patient. Pathogens (Basel, Switzerland) 11 (11) (2022)
Dalin Rifat, Si-Yang Li, Thomas Ioerger, Keshav Shah, Jean-Philippe Lanoix, Jin Lee, Ghader Bashiri, James Sacchettini, Eric L Nuermberger
Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 65 (1) (2020)
Pierre-Yves Boëlle, Tristan Delory, Xavier Maynadier, Cécile Janssen, Renaud Piarroux, Marie Pichenot, Xavier Lemaire, Nicolas Baclet, Pierre Weyrich, Hugues Melliez, Agnès Meybeck, Jean-Philippe Lanoix, Olivier Robineau
Trajectories of Hospitalization in COVID-19 Patients: An Observational Study in France. Journal of clinical medicine 9 (10) (2020)
Jean-Philippe Lanoix, Cédric Joseph, François Peltier, Sandrine Castelain, Claire Andréjak
Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection. Antimicrobial agents and chemotherapy 64 (5) (2020)
Jean-Philippe Lanoix, Rokeya Tasneen, Paul O'Brien, Jansy Sarathy, Hassan Safi, Michael Pinn, David Alland, Véronique Dartois, Eric Nuermberger
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis. Antimicrobial agents and chemotherapy 60 (7) (2016)
Youssef El Samad, Jean-Philippe Lanoix, Youssef Bennis, Momar Diouf, Carlo Saroufim, Benoit Brunschweiler, Florence Rousseau, Cédric Joseph, Farida Hamdad, Mohamed Ait Amer Meziane, Simon Routier, Jean-Luc Schmit
Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections. Antimicrobial agents and chemotherapy 60 (10) (2016)
Jean-Philippe Lanoix, Fabrice Betoudji, Eric Nuermberger
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis. Antimicrobial agents and chemotherapy 60 (2) (2015)
Jean-Philippe Lanoix, Thomas Ioerger, Aimee Ormond, Firat Kaya, James Sacchettini, Véronique Dartois, Eric Nuermberger
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum. Antimicrobial agents and chemotherapy 60 (2) (2015)